Elastagen Pty Ltd is a clinical-stage medical-device company that is pioneering Elastatherapy™, which uses the human protein elastin to naturally repair and augment the skin. The company has arisen out of patented research conducted by Prof. Tony Weiss’s group and the first clinical trials have demonstrated the biocompatability and safety of their synthetic human elastin in human subjects. Prof. Weiss’s work on elastin for burns treatment was highlighted in the 2010 AMMRF Profile. Elastagen is a venture-backed private company based in Sydney. Investors include ATP Innovations, Brandon Capital and GBS Ventures.
Enabled by the AMMRF at the University of Sydney